New European Respiratory Society (ERS) update makes sotatercept a strong add-on recommendation, opening a fourth pathway for pharmacists to manage.
|Articles|May 25, 2022
Daily OTC Pearl: Blood Pressure Supplement
Author(s)Saro Arakelians, PharmD
This product helps control blood pressure.
Advertisement
OTC/Lifestyle Pearl of the Day: Blood Pressure Supplement
Indication: Blood Pressure Supplement helps control blood pressure.
Insights:
- Contains folate, niacin, and vitamins Vitamin B6, B12, and C.
- 90 capsules per bottle
- Take as directed on the label or per the provider’s recommendations.
- Take separately from all other medications to avoid interactions.
Source:
Advertisement
Related to this article
Pharmacists are well equipped to manage DOAC therapy by providing initial education, adherence support, and safety monitoring.
Findings presented at the European Respiratory Society Congress 2026 suggest semaglutide may offer respiratory benefits beyond its approved diabetes and obesity indications.
Ataxia-telangiectasia (A-T) is a rare neurodegenerative disorder that primarily affects the nervous system, causing progressive loss of muscle control and coordination.
Study investigator David Berg explains why volume overload shouldn't decide which hospitalized patients get an SGLT2 inhibitor.
Most patients screened by a hospital pharmacist-led transitions-of-care service had unmet pneumococcal and other vaccine needs, and most accepted vaccination when offered.
The data helps pharmaicts predict who will react strongly to mRNA vaccines—giving them a science-backed talking point during respiratory season.
CDC-recommended adult vaccination programs for pneumococcal disease, RSV, influenza, and COVID-19 prevent over 182,000 deaths and generate up to $12 in societal value for every $1 spent.
Advertisement
Advertisement
Trending on Pharmacy Times
1
New Bladder Cancer Regimens Reshape Treatment Across Disease Stages
2
Dapagliflozin in Heart Failure: Congestion Isn't the Gatekeeper
3
Semaglutide Linked to Up to 40% Fewer Asthma Attacks, Real-World Data Show
4
FDA Approves Levacetylleucine to Treat Ataxia in Adult, Pediatric Patients With A-T
5